글로벌 간염 검사 솔루션/진단 시장 – 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 글로벌 간염 검사 솔루션/진단 시장

간염 검사 솔루션/진단 시장은 2021년에서 2028년의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 위에서 언급한 예측 기간 동안 시장이 4.55%의 CAGR로 성장할 것으로 분석합니다. 전 세계적으로 간염 질환의 발병률이 증가하고 바이러스 유형을 판별하는 진단 시스템에 대한 필요성이 간염 검사 솔루션/진단 시장을 주도합니다.

간염은 여러 가지 유형의 간에 생기는 염증을 말합니다. 또한 A형, B형, C형 간염이라는 여러 가지 유형의 바이러스로 구분됩니다. 이 질병의 진단은 각 바이러스에 대한 혈액 검사를 통해 이루어지며, 바이러스와 관련된 항체를 검사하는 방법도 있습니다. 또한 바이러스의 일부인 신체의 유전 물질이나 단백질을 검사하여 간염의 유형을 진단하는 방법도 있습니다.

간염 바이러스 검사의 이점에 대한 인식이 높아지면서 올바른  치료  및 예방 과정을 계획하는 데 도움이 되는 것은 시장 성장을 확대하는 중요한 요인이며, 또한 라이프스타일과 음식 소비 습관의 변화, 약물의 부작용 증가, 과도한 알코올 소비, 바이러스성 간염 및 자가면역 질환의 발생률 증가, 소비자의 가처분 소득 증가, 의료 관광 증가, 진단되지 않은 인구의 대규모 인구 증가는 간염 검사 솔루션/진단 시장을 주도하는 주요 요인 중 하나입니다. 또한, 의료 분야의 기술 발전과 현대화 증가, 의료 분야의 연구 개발 활동 증가, 노령 인구 기반이 증가하는 신흥 시장이 증가하면서 2021-2028년 예측 기간 동안 간염 검사 솔루션/진단 시장에 새로운 기회가 창출될 것입니다.

However, rising cost of NAT (Nucleic Acid Amplification Testing) and rising lack of any executive compulsory directive issued by the authorities in developing countries regarding the testing for hepatitis virus are the major factors among others which will obstruct the market growth, and will further challenge the growth of hepatitis test solution/diagnosis market in the forecast period mentioned above.

This hepatitis test solution/diagnosis market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on hepatitis test solution/diagnosis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Hepatitis Test Solution/Diagnosis Market Scope and Market Size

Hepatitis test solution/diagnosis market is segmented on the basis of tests, disease type, technology and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of tests, the hepatitis test solution/diagnosis market is segmented into blood tests, imaging tests and liver biopsy.
• Based on disease type, the hepatitis test solution/diagnosis market is segmented into hepatitis B, hepatitis C and other.
• Based on technology, the hepatitis test solution/diagnosis market is segmented into ELISA, rapid diagnostics test, PCR, INAAT and others.
• The hepatitis test solution/diagnosis market is also segmented on the basis of role of end-user into hospitals, diagnostic labs, blood banks, clinics and others.

Hepatitis Test Solution/Diagnosis Market Country Level Analysis

Hepatitis test solution/diagnosis market is analysed and market size insights and trends are provided by country, product type, application and role of administration as referenced above.

The countries covered in the hepatitis test solution/diagnosis market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the hepatitis test solution/diagnosis market due to increasing uptake of advanced technologies and the presence of a sophisticated healthcare network in this region.

The country section of the hepatitis test solution/diagnosis market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

Hepatitis test solution/diagnosis market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for hepatitis test solution/diagnosis market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the hepatitis test solution/diagnosis market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Hepatitis Test Solution/Diagnosis Market Share Analysis

Hepatitis test solution/diagnosis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to hepatitis test solution/diagnosis market.

간염 검사 솔루션/진단 시장 보고서에서 다루는 주요 업체는 F. Hoffmann-La Roche Ltd, Abbott, Bio-Rad Laboratories Inc., Siemens, DiaSorin, QIAGEN, Danaher, bioMérieux SA, Grifols SA, Ortho Clinical Diagnostics, FUJIREBIO Inc., Avantor Inc., Quest Diagnostics Incorporated, MedMira Inc., Laboratory Corporation of America Holdings, Cigna, OraSure Technologies Inc. 등 국내 및 글로벌 업체입니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA) 및 남미에 대해 개별적으로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 개별적으로 제공합니다.

SKU-27937